Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Eznollah Azargashb
Correction To: Efficacy and Safety of Duloxetine and Pregabalin in Iranian Patients With Diabetic Peripheral Neuropathic Pain: A Double-Blind, Randomized Clinical Trial
Journal of Diabetes and Metabolic Disorders
Internal Medicine
Endocrinology
Metabolism
Diabetes
The Effect of Topical Vitamin a and E on Ischemic Random Skin Flap Survival
WORLD JOURNAL OF PLASTIC SURGERY
Related publications
Efficacy of Pregabalin in Post-Traumatic Peripheral Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial
Journal of Neurology
Neurology
Meta-Analysis of Duloxetine vs. Pregabalin and Gabapentin in the Treatment of Diabetic Peripheral Neuropathic Pain
BMC Neurology
Medicine
Neurology
A Randomized Trial of Pregabalin in Patients With Neuropathic Pain Due to Spinal Cord Injury
Neurology
Neurology
Treating Low Back Pain With Combined Cerebral and Peripheral Electrical Stimulation: A Randomized, Double-Blind, Factorial Clinical Trial
European Journal of Pain
Medicine
Anesthesiology
Pain Medicine
Additive Duloxetine for Cancer-Related Neuropathic Pain Nonresponsive or Intolerant to Opioid-Pregabalin Therapy: A Randomized Controlled Trial (JORTC-PAL08)
Journal of Pain and Symptom Management
Neurology
Anesthesiology
Pain Medicine
Nursing
Efficacy and Safety of Mirogabalin (DS-5565) for the Treatment of Diabetic Peripheral Neuropathic Pain: A Randomized, Double-Blind, Placebo- And Active Comparator–Controlled, Adaptive Proof-Of-Concept Phase 2 Study
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Endogenous Analgesic Effect of Pregabalin: A Double-Blind and Randomized Controlled Trial
European Journal of Pain
Medicine
Anesthesiology
Pain Medicine
A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Duloxetine in Japanese Fibromyalgia Patients
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
Safety and Radiosensitizing Efficacy of Sanazole (AK 2123) in Oropharyngeal Cancers: Randomized Controlled Double Blind Clinical Trial
Indian Journal of Cancer
Oncology